Sutro Biopharma (STRO) EBIT Margin (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,656.00 |
| Sep 30, 2025 | -49,469.00 |
| Jun 30, 2025 | 119,675.00 |
| Mar 31, 2025 | -76,134.00 |
| Dec 31, 2024 | 35,651.00 |
| Sep 30, 2024 | -52,366.00 |
| Jun 30, 2024 | 16,154.00 |
| Mar 31, 2024 | -47,299.00 |
| Dec 31, 2023 | 29,801.00 |
| Sep 30, 2023 | 18,345.00 |
| Jun 30, 2023 | -11,026.00 |
| Mar 31, 2023 | 23,697.00 |
| Dec 31, 2022 | -48,588.00 |
| Sep 30, 2022 | -1,537.00 |
| Jun 30, 2022 | 59,462.00 |
| Mar 31, 2022 | -33,474.00 |
| Dec 31, 2021 | 7,826.00 |
| Sep 30, 2021 | -37,216.00 |
| Jun 30, 2021 | 9,471.00 |
| Mar 31, 2021 | 17,044.00 |
| Dec 31, 2020 | -24,054.00 |
| Sep 30, 2020 | 11,381.00 |
| Jun 30, 2020 | 9,480.00 |
| Mar 31, 2020 | -13,742.00 |
| Dec 31, 2019 | -2,703.00 |
| Sep 30, 2019 | 2,629.00 |
| Jun 30, 2019 | 3,530.00 |
| Mar 31, 2019 | -14,817.00 |
| Dec 31, 2018 | 11,246.00 |
| Sep 30, 2018 | 8,230.00 |
| Jun 30, 2018 | -990.00 |
| Mar 31, 2018 | 17,343.00 |
| Dec 31, 2017 | -36,936.00 |